Background Current National Institutes of Health (NIH) policy mandates the inclusion of women, minorities and children in clinical research. Institutional Review Boards (IRB), NIH Scientific Review Groups (SRG) and NIH program staff all have responsibility for the evaluation of Principal Investigator (PI) adherence to the inclusion guidelines. Purpose The purpose of this survey was to describe the experience with and attitudes of SRG members toward the inclusion guidelines and to identify characteristics of respondents that predict their attitudes towards the policy. Methods A survey was sent to 746 SRG members. 425 SRG members responded and univariate and bivariate statistical analysis conducted.
Introduction
In March of 1994, the National Institutes of Health (NIH) released guidelines mandating the inclusion of women and minorities in clinical research [1] . Four years later, the NIH released similar guidelines mandating the inclusion of children [2] . These 'inclusion guidelines' were created to increase the representation of women, minorities and children in clinical research to address potential harms (real and perceived) created by their exclusion or omission. As designated in the guidelines, NIH Scientific Review Groups (SRG) share the responsibility for the evaluation of Principal Investigator (PI) adherence to the inclusion guidelines with local Institutional Review Boards (IRBs) and NIH Program Staff [1, 2] . The purpose of this survey was to: describe the experience with and attitudes of SRG members toward the inclusion guidelines and to identify characteristics of respondents that predict their attitudes towards the policy.
Background
Scientific Review Group (SRG) members are scientific experts from academia, industry, and nonprofit research organizations. The primary role of the SRG is to assess the scientific merit of research proposals to the NIH based on the NIHdefined criteria of significance, approach, innovation of proposal, quality of the investigator, and scientific environment. Decisions made by SRGs determine whether an application ought to be considered for funding by a particular NIH institute, center or division (ICD). The SRG's assessment of a PIs adherence to the inclusion guidelines are incorporated into their scoring of the application [1] [2] [3] [4] . Reviewers are instructed to increase the score of a proposal if 'inclusion of these groups is inadequate to answer the scientific objective of the proposed study' and justification for their exclusion is inadequate. (The higher the score, the less likely the proposal will be funded.) The SRG has discretion as to the amount of weight to give to this deficiency (i.e., there is not a standard reduction suggested); further, the SRG has the option of designating a protocol as unacceptable if it substantially fails to conform to the guidelines [3] . The SRG's willingness to use this power may be related to the attitudes of SRG members regarding what human factors are important to diversity in study populations and whether they consider the NIH policy useful in encouraging such diversity.
Methods

Sample
The Office of Extramural Research (OER), NIH website [5] provides a narrative describing the purview of each SRG and posts member rosters from recent meetings. Eligible subjects were sampled from SRGs that have responsibility for reviewing research proposals that may include human subjects. Six SRGs who appeared to regularly review human subject research but had not met in the last calendar year and six SRGs for which no current roster of members was posted were excluded from the sample. A master list of all eligible members for inclusion was created. All Committee Chairs were included in the sample (n ¼ 70). A random sample of 746 members was created from a list of close to 1400 non-Chair members [6] .
Recruitment
Once the random sample was created, complete mailing addresses were collected via a comprehensive web-search (e.g., Google and/or Institutional Faculty/Employee Databases). All eligible subjects were mailed a letter describing the study and a hard copy of the questionnaire. The first mailing was sent in April 2003 to coordinate with reviews scheduled for and conducted in January-March 2003. Two weeks after the first survey package was sent a reminder postcard was sent to all nonresponders. Four weeks after the original mailing, a second mailing with a letter and copy of the survey was sent.
Each subject was given a unique identifier (UI) in order to track and follow-up with non-responders. When the survey was returned it was dated and given a new number in order of receipt date. Once processed it was impossible to link survey responses with an individual respondent.
Survey
Survey domains and questions were developed based on documents that detail SRG responsibilities regarding the implementation of the NIH Guidelines [3, 5] . Drafts of the survey were reviewed by an expert in survey design and cognitive interviews were conducted with three local colleagues who had served on an SRG. Survey domains included: basic details about their SRG experience, attitudes about diversity in general and diversity in study samples, experience with implementation of each of the set of NIH guidelines and basic demographic information including their area of expertise.
All respondents were asked to complete the demographic questions and survey questions regarding their attitudes and opinions about evaluating the diversity of study samples. Independent variables of interest were: gender; race/ethnicity; personal experience with research, completion of an ethics course; IRB service; more than 5 years experience on an SRG; SRG chair service; more than 50% of protocols reviewed as most recent SRG meeting included human subjects; agreement with the importance of gender, race, age, socioeconomic status (SES), and genotype in the assessment of the diversity of a study population; and which subject factor is most important in assessing the diversity of a study population.
The dependent variables of interest were: whether the guidelines are in part responsible for the amount of attention given by their SRG to inclusion of women, minorities, and children; whether they believe investigators whose grant applications are reviewed by their SRG consistently address the inclusion of women, minorities, and children in their applications; whether the number of women, minorities, and children included in clinical research has increased as a result of investigator compliance with the guidelines; whether subject factors related to diversity are frequently discussed during SRG meetings; and whether current NIH policy regarding factors related to the diversity of a study population is adequate.
Data from returned surveys were entered into an Excel database and later uploaded into STATA, version 7.0, statistical software for analysis [6] . Descriptive univariate analysis was conducted followed by bivariate analysis. A number of questions required respondents to indicate whether they 'strongly agree, agree, neither agree nor disagree, disagree, or strongly disagree' with statements about the study sample diversity and the NIH guidelines. Based on the characteristics of the variable distributions, these responses were collapsed such that those who were neutral, disagreed or strongly disagreed were combined and compared with those who agreed or strongly agreed.
Results
Response Two postcards were returned as 'undeliverable'. Twenty-five subjects either returned blank surveys or sent an e-mail noting they did not believe they were eligible for participation. A total of 425 completed surveys were returned (overall response rate ¼ 425/746 ¼ 56.9%).
Demographics
Of the 425 respondents, two-thirds (66%) were male and 85% were white. Seventy-nine percent of respondents held a PhD and 77% reported personal experience conducting research. Sixty-nine percent of respondents completed an ethics course and 28% served on an IRB.
Eighty-seven percent of respondents were members of standing committees and had a mean tenure of 2.9 years on their current committee. The remaining 13% were members of Special Emphasis Panels (SEPs). SEPs are brought together for the review of a particular set of research proposals or for the review of protocols submitted in response to a particular request for applications (RFA) or request for proposals (RFP) that requires expertise not available on standing committees. Fifty-four percent of respondents reported they had more than 5 years of cumulative experience on an SRG. Twenty-three percent of the respondents are Committee Chairs. Ninety-five percent of respondents reported their SRG meets three times a year and 65% attended a committee meeting less than 2 months prior to completing the survey (Tables 1 and 2) .
Respondent opinions about study sample diversity
Ninety-seven percent (n ¼ 415) of respondents agreed that particular human characteristicsgender, race, age, socioeconomic status (SES), and genotype -were important when evaluating the diversity of human subjects to be included in a study sample. Results are presented in Table 3 .
Most important factor
Respondents were also asked to identify which of the above factors was the most important when evaluating the diversity of a study population. Forty-five percent of respondents indicated that gender is as the most important factor (Table 3) . Thirty respondents refused to answer this question, a number noting that no one factor can be identified as 'most important.' Non-white respondents were more likely than white respondents to agree that gender ( p ¼ 0.025) or race ( p ¼ 0.025) is the most important factor. Female respondents were no more likely than male respondents to agree that gender or race was the most important factor ( p ¼ 0.121 and p ¼ 0.577).
Respondent attitudes, beliefs and opinions about inclusion guidelines
Respondents who indicated that they reviewed human subject research at their last meeting (n ¼ 375; 88% of sample) were asked to indicate their level of agreement statements about the guidelines regarding the inclusion of women, minorities, and children.
Role of policy
The majority of respondents agreed that the inclusion guidelines were in part responsible for their study sections' attention to the inclusion of women (84%), minorities (88%), and children (77%) in human subject research (Table 4 ). Respondents were more likely to agree that guidelines were in part responsible for SRG attention to inclusion of minorities if they had taken an ethics course ( p ¼ 0.018) or if they had served on an IRB ( p ¼ 0.026).
Consistency of policy implementation
The majority of respondents agreed that investigators whose grant applications were reviewed by their study section consistently address the inclusion of women (84%), minorities (83%), and children (72%) in their grant applications (Table 4 ). Respondents were more likely to agree that investigators were consistent with minority and gender guidelines if they reported having conducted research themselves (minority p ¼ 0.001; gender p ¼ 0.000), having taken an ethics course (minority p ¼ 0.001; gender p ¼ 0.0004), or that more than 50% of the proposals reviewed at their last committee meeting proposed to include human subjects (minority p ¼ 0.03; gender p ¼ 0.001).
Implementation related increase in inclusion
Just over half of the respondents agreed that the number of women (54%) and minorities (56%) included in clinical research has increased as a result of investigator compliance with the inclusion guidelines. Only 30% of the respondents agreed that the number of children included in clinical research had increased as a result of investigator compliance with the guidelines (Table 4 ).
Discussions about diversity
Respondents also were asked whether the factors of gender, race age, SES, and genotype are frequent topics of discussion in reference to the diversity of study samples proposed in proposals under review during study section meetings ( Table 5 ).
Adequacy of current policy
In follow-up, respondents were asked if they believed that the current NIH guidelines adequately address the importance of each of these factors in evaluating the diversity of study samples (Table 6 ). 
Discussion
The results presented here indicate that the NIH inclusion guidelines may have had an influence on the attitudes of SRG members in a number of ways. First, the majority of respondents indicate that gender and race are the most important factors when assessing the diversity of study samples and that the NIH guidelines regarding the inclusion of women and minorities are adequate to encourage their inclusion. Second, the majority of respondents also indicate that age is an important factor when assessing the diversity of study samples and that the current NIH guidelines are adequate. What is not clear, given the way in which the question is asked (importance of age rather than inclusion of children or older adults), is whether respondents believe that variation in age or inclusion of more younger or older subjects is important. Given respondent agreement that NIH guidelines regarding age are adequate, we can conclude that respondents are satisfied with the emphasis of the current guidelines that encourage the inclusion of children. Respondents were not asked if they believe it would be important to encourage the enrollment of older adults (for which NIH has no policy to encourage enrollment), which may become more important as the population ages. Of note, SRG members do not agree that SES is as important a factor as gender and race in assessing the diversity of a study sample. In addition, the SRG members report that they believe the guidelines have influenced outcomes relevant to the successful implementation of the inclusion guidelines. More than two-thirds of the respondents indicated that gender and race and the diversity of study samples were frequent topics of conversation in their study sections and the majority of SRG members agreed that the guidelines were in part responsible for their attention to issues related to the inclusion of women, minorities and children in human subject research. SRG members in this sample generally agreed that PIs of grant proposals have been consistent in their compliance with the inclusion guidelines. One limitation of the role of SRG members' ability to assess PI compliance is that they only review the PIs' intent to adhere to the guidelines as described in their grant application.
Those SRG members that have experience conducting research, report having reviewed human subject research or have taken an ethics course are more likely to agree that investigators have been consistent with the inclusion guidelines. None of these respondent characteristics predict agreement that investigators have been consistent in their compliance with the guidelines regarding the inclusion of children.
About half of the SRG members in the sample agree that the inclusion guidelines have resulted in an increase in the number of women and minorities enrolled in clinical research (54 and 56%, respectively). Less than a third of SRG members (30%) indicate that the guidelines encouraging the inclusion of children has lead to an increase of children in clinical trials. The amount of agreement regarding this outcome may be related to the SRG members' hesitance to support a statement about an outcome which is distal to their role in the assessment process.
Corbie-Smith, Durant and St. George found in their survey of National Heart, Lung and Blood Institute (NHLBI) funded principal investigators that 69% agreed that the inclusion guidelines had been successful in increasing gender diversity and 55% agreed the guidelines had been successful in increasing the number of minorities enrolled in clinical trials [7] . Compared to the results presented in this paper, PIs are more likely than SRG members to agree that the guidelines have been successful in increasing the number of women. PIs and SRG members were similarly unenthusiastic about the influence of the guidelines on increasing the number of minorities in research.
It is important to note that there are alternative ways to assess whether the implementation of the inclusion guidelines have been successful. The NIH Office for Research on Women's Health (OWRH) is the NIH office responsible for monitoring compliance with the guidelines. According to the ORWH's last fiscal year report 2003 & 2004 [8] , 57.5% of human subjects enrolled in all clinical studies were female, 52% were white, 8.9% were African American, 28% were Asian, 1% were American Indian/Alaska Native, and Hawaii/Pacific Islanders combined, and 4.8% of human subjects were of Hispanic/Latino ethnicity. The number of women and minorities enrolled in research has remained stable since the system has been in place, however [9] [10] [11] [12] [13] . There was no rigorous accounting system in place prior to the implementation of the 1994 guidelines so it is impossible to know if the adoption of the guidelines resulted in an increase in enrollment among these groups.
Other investigators have attempted to assess the influence of the guidelines on the inclusion of women and minorities by conducting literature searches and assessing if and how data regarding the sex and race/ethnicity of study populations is documented. Geller et al. [14] conclude as a result of their review of 69 Federally-funded studies published in high impact medical journals in 2004 that there is inadequate compliance with the NIH guidelines. Using similar methods applied to articles published in six leading journals in 1999, Rochon et al. [15] conclude that articles reporting the results of NIH-funded research where more likely to report minority group status of study populations as compared to non-NIH funded research. Such studies have the potential to indicate the influence of the guidelines on the inclusion of women and minorities in research if future studies are conducted to assess the diversity of study populations before and after the guidelines were implemented.
It is also important to note that SRGs are not the only groups responsible for the assessing PI adherence to the guidelines. The Institutional Review Board (IRB) has the opportunity to assess individual PI compliance with the guidelines in the process of their annual review of approved protocols if investigators are asked to provide updates of the sex and race/ethnicity of subjects recruited in the previous year. NIH project officers review recruitment reports submitted annually by PIs and are therefore able to assess PI compliance with the guidelines. There is currently no empirical data available regarding whether or how often IRBs or NIH project officers assess PI's success in recruiting as diverse a population as proposed or whether the continuation of the IRB approval or continuation of funding is contingent on evidence of success.
At least one potential limitation of this study is that while an effort was made to assure confidentiality, because the project was funded by the NIH, respondents may have been less critical of the guidelines than they would have been if the study was funded by non-NIH funds. This funding arrangement may have also influenced SRG members' willingness to return the survey in the first place.
Conclusion
This survey identifies one measure of success regarding the implementation of the NIH guidelines; SRG members indicate the guidelines are in part responsible for their attention to the inclusion of women, minorities, and children in clinical research. In addition, SRG members believe that gender and race are important factors when assessing the diversity of study samples and that the current NIH guidelines are adequate for encouraging their inclusion. As a proxy measure of success, SRG members believe that PIs responsible for protocols reviewed by their study group are generally compliant with the inclusion guidelines. Future research ought to explore whether IRB members and NIH program officers find PIs to be compliant as their projects get underway. In addition, more research ought to be conducted to assess the downstream effects of this important social policy. For example, whether PI compliance with the NIH guidelines leads to evidence in the research literature that women, minorities and children are well represented in clinical trials, whether research results vary by sub-groups and whether the conduct of such research results in the adoption of treatment recommendations tailored for different populations [16, 17] .
